Skip to content

Clinical trials

Terminated Biliary Tract Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Biliary Tract Neoplasms Status: Terminated Country / region: United States Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20071
20092
20121
20131
20142
20172
20196
20203
20211
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital2
Mayo Clinic2
AbGenomics B.V Taiwan Branch1
BioNTech SE1
Black Diamond Therapeutics, Inc.1
Bolt Biotherapeutics, Inc.1
Bristol-Myers Squibb1
Columbia University1
CureOne1
EMD Serono Research & Development Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Biliary Tract Neoplasms26
Cholangiocarcinoma15
Stomach Neoplasms7
Gallbladder Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Pancreatic Neoplasms5
Colorectal Neoplasms4
Bile Duct Neoplasms3
Breast Neoplasms3
Carcinoma, Hepatocellular3

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.